Drug Approval | March 01, 2024
Biocon Biologics secures US market entry date for Bmab 1200
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
Additionally, an MoU was signed between the Dental Council of India and Quality Council of India for the assessment and rating of undergraduate dental colleges
The brands Aarne in Germany and Nalcrom in Canada and the Netherlands are being acquired
Additionally, Rs. 12.85 crores shall be infused into the P H Diagnostic by way of either Equity or Loan to pay the existing debt
Total transaction value of the divestment is Rs. 3,660 million
This product will be manufactured at Lupin's Nagpur facility in India
Tele-MANAS has counseled more than 3,50,000 people till date and currently provides counseling to 2000 people through 44 Tele Manas Cells
Lupin actively contributes to alleviating the burden of COPD for patients across the nation
Pratima takes on the role of Country Speaker in addition to her role as GM and MD of Merck Specialties in India
Intent to start at least 5 innovative Phase 3 vaccine programs by 2025
Subscribe To Our Newsletter & Stay Updated
